CHEMED CORP (CHE) Fundamental Analysis & Valuation

NYSE:CHE • US16359R1032

Current stock price

373.79 USD
-11.98 (-3.11%)
At close:
373.79 USD
0 (0%)
After Hours:

This CHE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. CHE Profitability Analysis

1.1 Basic Checks

  • In the past year CHE was profitable.
  • In the past year CHE had a positive cash flow from operations.
  • In the past 5 years CHE has always been profitable.
  • In the past 5 years CHE always reported a positive cash flow from operatings.
CHE Yearly Net Income VS EBIT VS OCF VS FCFCHE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

1.2 Ratios

  • CHE's Return On Assets of 17.24% is amongst the best of the industry. CHE outperforms 100.00% of its industry peers.
  • Looking at the Return On Equity, with a value of 27.08%, CHE belongs to the top of the industry, outperforming 94.00% of the companies in the same industry.
  • CHE's Return On Invested Capital of 21.08% is amongst the best of the industry. CHE outperforms 95.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CHE is significantly above the industry average of 8.51%.
  • The 3 year average ROIC (21.04%) for CHE is below the current ROIC(21.08%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 17.24%
ROE 27.08%
ROIC 21.08%
ROA(3y)17.23%
ROA(5y)17.8%
ROE(3y)26.22%
ROE(5y)30.6%
ROIC(3y)21.04%
ROIC(5y)22.31%
CHE Yearly ROA, ROE, ROICCHE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

1.3 Margins

  • Looking at the Profit Margin, with a value of 10.48%, CHE belongs to the top of the industry, outperforming 97.00% of the companies in the same industry.
  • CHE's Profit Margin has declined in the last couple of years.
  • With an excellent Operating Margin value of 14.01%, CHE belongs to the best of the industry, outperforming 87.00% of the companies in the same industry.
  • CHE's Operating Margin has declined in the last couple of years.
  • CHE's Gross Margin of 32.54% is fine compared to the rest of the industry. CHE outperforms 66.00% of its industry peers.
  • In the last couple of years the Gross Margin of CHE has remained more or less at the same level.
Industry RankSector Rank
OM 14.01%
PM (TTM) 10.48%
GM 32.54%
OM growth 3Y-4.39%
OM growth 5Y-2.39%
PM growth 3Y-3.57%
PM growth 5Y-7.36%
GM growth 3Y-3.17%
GM growth 5Y-0.72%
CHE Yearly Profit, Operating, Gross MarginsCHE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. CHE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CHE is creating value.
  • The number of shares outstanding for CHE has been reduced compared to 1 year ago.
  • CHE has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CHE has a worse debt to assets ratio.
CHE Yearly Shares OutstandingCHE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
CHE Yearly Total Debt VS Total AssetsCHE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • CHE has an Altman-Z score of 11.16. This indicates that CHE is financially healthy and has little risk of bankruptcy at the moment.
  • CHE has a Altman-Z score of 11.16. This is amongst the best in the industry. CHE outperforms 96.00% of its industry peers.
  • The Debt to FCF ratio of CHE is 0.03, which is an excellent value as it means it would take CHE, only 0.03 years of fcf income to pay off all of its debts.
  • CHE has a better Debt to FCF ratio (0.03) than 92.00% of its industry peers.
  • CHE has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • CHE has a Debt to Equity ratio of 0.01. This is amongst the best in the industry. CHE outperforms 83.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.03
Altman-Z 11.16
ROIC/WACC2.37
WACC8.91%
CHE Yearly LT Debt VS Equity VS FCFCHE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 1.05 indicates that CHE should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.05, CHE is doing worse than 66.00% of the companies in the same industry.
  • CHE has a Quick Ratio of 1.03. This is a normal value and indicates that CHE is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of CHE (1.03) is worse than 64.00% of its industry peers.
  • The current and quick ratio evaluation for CHE is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.03
CHE Yearly Current Assets VS Current LiabilitesCHE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CHE Growth Analysis

3.1 Past

  • CHE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.70%.
  • CHE shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.61% yearly.
  • The Revenue has been growing slightly by 4.06% in the past year.
  • Measured over the past years, CHE shows a small growth in Revenue. The Revenue has been growing by 4.00% on average per year.
EPS 1Y (TTM)-6.7%
EPS 3Y3%
EPS 5Y3.61%
EPS Q2Q%-6%
Revenue 1Y (TTM)4.06%
Revenue growth 3Y5.82%
Revenue growth 5Y4%
Sales Q2Q%-0.1%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.57% on average over the next years. This is quite good.
  • CHE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.67% yearly.
EPS Next Y11.69%
EPS Next 2Y11.6%
EPS Next 3Y10.57%
EPS Next 5YN/A
Revenue Next Year4.7%
Revenue Next 2Y5.46%
Revenue Next 3Y5.67%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CHE Yearly Revenue VS EstimatesCHE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
CHE Yearly EPS VS EstimatesCHE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10 15 20 25

More info and screens

Find the best growth stocksShow best growing peers

5

4. CHE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 17.31, the valuation of CHE can be described as rather expensive.
  • CHE's Price/Earnings ratio is a bit cheaper when compared to the industry. CHE is cheaper than 75.00% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of CHE to the average of the S&P500 Index (27.71), we can say CHE is valued slightly cheaper.
  • The Price/Forward Earnings ratio is 15.50, which indicates a correct valuation of CHE.
  • Based on the Price/Forward Earnings ratio, CHE is valued a bit cheaper than the industry average as 73.00% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 38.09, CHE is valued rather cheaply.
Industry RankSector Rank
PE 17.31
Fwd PE 15.5
CHE Price Earnings VS Forward Price EarningsCHE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 61.00% of the companies in the same industry are more expensive than CHE, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CHE indicates a somewhat cheap valuation: CHE is cheaper than 70.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.78
EV/EBITDA 13.27
CHE Per share dataCHE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

  • CHE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CHE has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.48
PEG (5Y)4.79
EPS Next 2Y11.6%
EPS Next 3Y10.57%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. CHE Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.63%, CHE is not a good candidate for dividend investing.
  • CHE's Dividend Yield is rather good when compared to the industry average which is at 0.48. CHE pays more dividend than 81.00% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, CHE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.63%

5.2 History

  • On average, the dividend of CHE grows each year by 11.06%, which is quite nice.
  • CHE has paid a dividend for at least 10 years, which is a reliable track record.
  • CHE has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)11.06%
Div Incr Years17
Div Non Decr Years22
CHE Yearly Dividends per shareCHE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • 11.95% of the earnings are spent on dividend by CHE. This is a low number and sustainable payout ratio.
  • The dividend of CHE is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP11.95%
EPS Next 2Y11.6%
EPS Next 3Y10.57%
CHE Yearly Income VS Free CF VS DividendCHE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
CHE Dividend Payout.CHE Dividend Payout, showing the Payout Ratio.CHE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CHE Fundamentals: All Metrics, Ratios and Statistics

CHEMED CORP

NYSE:CHE (4/21/2026, 8:04:00 PM)

After market: 373.79 0 (0%)

373.79

-11.98 (-3.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25
Earnings (Next)04-23
Inst Owners104.27%
Inst Owner Change0.03%
Ins Owners1.51%
Ins Owner Change-1.34%
Market Cap5.46B
Revenue(TTM)2.53B
Net Income(TTM)265.24M
Analysts75
Price Target451.86 (20.89%)
Short Float %3.62%
Short Ratio1.9
Dividend
Industry RankSector Rank
Dividend Yield 0.63%
Yearly Dividend2.24
Dividend Growth(5Y)11.06%
DP11.95%
Div Incr Years17
Div Non Decr Years22
Ex-Date02-23
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.47%
Min EPS beat(2)-10.06%
Max EPS beat(2)-2.88%
EPS beat(4)1
Avg EPS beat(4)-6.89%
Min EPS beat(4)-15.11%
Max EPS beat(4)0.5%
EPS beat(8)1
Avg EPS beat(8)-5.02%
EPS beat(12)3
Avg EPS beat(12)-3.1%
EPS beat(16)7
Avg EPS beat(16)-1.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.56%
Min Revenue beat(2)-3.96%
Max Revenue beat(2)-1.17%
Revenue beat(4)0
Avg Revenue beat(4)-1.96%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)-0.19%
Revenue beat(8)0
Avg Revenue beat(8)-1.64%
Revenue beat(12)2
Avg Revenue beat(12)-1.3%
Revenue beat(16)2
Avg Revenue beat(16)-1.4%
PT rev (1m)-20.25%
PT rev (3m)-22.86%
EPS NQ rev (1m)-3.33%
EPS NQ rev (3m)-11.53%
EPS NY rev (1m)-0.56%
EPS NY rev (3m)-6.29%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)-2.46%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-1.43%
Valuation
Industry RankSector Rank
PE 17.31
Fwd PE 15.5
P/S 2.16
P/FCF 16.78
P/OCF 14.07
P/B 5.58
P/tB 23.78
EV/EBITDA 13.27
EPS(TTM)21.59
EY5.78%
EPS(NY)24.11
Fwd EY6.45%
FCF(TTM)22.28
FCFY5.96%
OCF(TTM)26.58
OCFY7.11%
SpS173.17
BVpS67.04
TBVpS15.72
PEG (NY)1.48
PEG (5Y)4.79
Graham Number180.457 (-51.72%)
Profitability
Industry RankSector Rank
ROA 17.24%
ROE 27.08%
ROCE 28.33%
ROIC 21.08%
ROICexc 22.41%
ROICexgc 60.78%
OM 14.01%
PM (TTM) 10.48%
GM 32.54%
FCFM 12.86%
ROA(3y)17.23%
ROA(5y)17.8%
ROE(3y)26.22%
ROE(5y)30.6%
ROIC(3y)21.04%
ROIC(5y)22.31%
ROICexc(3y)24.14%
ROICexc(5y)24.65%
ROICexgc(3y)64.18%
ROICexgc(5y)68.12%
ROCE(3y)28.21%
ROCE(5y)29.9%
ROICexgc growth 3Y-2.67%
ROICexgc growth 5Y-7.4%
ROICexc growth 3Y-2.26%
ROICexc growth 5Y-2.45%
OM growth 3Y-4.39%
OM growth 5Y-2.39%
PM growth 3Y-3.57%
PM growth 5Y-7.36%
GM growth 3Y-3.17%
GM growth 5Y-0.72%
F-Score6
Asset Turnover1.64
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.03
Debt/EBITDA 0.03
Cap/Depr 96.84%
Cap/Sales 2.48%
Interest Coverage 263.51
Cash Conversion 92.61%
Profit Quality 122.71%
Current Ratio 1.05
Quick Ratio 1.03
Altman-Z 11.16
F-Score6
WACC8.91%
ROIC/WACC2.37
Cap/Depr(3y)89.6%
Cap/Depr(5y)92.99%
Cap/Sales(3y)2.34%
Cap/Sales(5y)2.49%
Profit Quality(3y)114.97%
Profit Quality(5y)107.83%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.7%
EPS 3Y3%
EPS 5Y3.61%
EPS Q2Q%-6%
EPS Next Y11.69%
EPS Next 2Y11.6%
EPS Next 3Y10.57%
EPS Next 5YN/A
Revenue 1Y (TTM)4.06%
Revenue growth 3Y5.82%
Revenue growth 5Y4%
Sales Q2Q%-0.1%
Revenue Next Year4.7%
Revenue Next 2Y5.46%
Revenue Next 3Y5.67%
Revenue Next 5YN/A
EBIT growth 1Y-12.87%
EBIT growth 3Y1.18%
EBIT growth 5Y1.52%
EBIT Next Year25.06%
EBIT Next 3Y13.68%
EBIT Next 5YN/A
FCF growth 1Y-11.55%
FCF growth 3Y8.82%
FCF growth 5Y-5.44%
OCF growth 1Y-7%
OCF growth 3Y7.8%
OCF growth 5Y-4.52%

CHEMED CORP / CHE Fundamental Analysis FAQ

What is the fundamental rating for CHE stock?

ChartMill assigns a fundamental rating of 7 / 10 to CHE.


What is the valuation status of CHEMED CORP (CHE) stock?

ChartMill assigns a valuation rating of 5 / 10 to CHEMED CORP (CHE). This can be considered as Fairly Valued.


What is the profitability of CHE stock?

CHEMED CORP (CHE) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for CHE stock?

The Price/Earnings (PE) ratio for CHEMED CORP (CHE) is 17.31 and the Price/Book (PB) ratio is 5.58.


What is the financial health of CHEMED CORP (CHE) stock?

The financial health rating of CHEMED CORP (CHE) is 8 / 10.